Loading...

Home
ETF
MYNZ

MYNZ

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

MYNZ News

Mainz Biomed to Present at Digestive Disease Week 2026

Feb 24 2026Newsfilter

Mainz Biomed Secures $6 Million Financing for Strategic Shift

Feb 17 2026seekingalpha

Mainz Biomed Secures $6 Million Funding to Enhance Liquidity and Focus on Pancreatic Cancer Detection

Feb 17 2026Newsfilter

Mainz Biomed Launches eAArly DETECT 2 Clinical Study Covering 2,000 Patients

Jan 05 2026Globenewswire

Mainz Biomed Integrates ColoAlert® Test into DoctorBox Platform in Germany

Dec 02 2025Globenewswire

Mainz Biomed Partners with DoctorBox to Launch ColoAlert Test in Germany

Dec 02 2025Newsfilter

Mainz Biomed and OncoVanguard8 Partner to Introduce ColoAlert in South America

Nov 18 2025Newsfilter

Mainz Biomed to Showcase ColoAlert, Its Leading Product, at MEDICA 2025

Nov 12 2025NASDAQ.COM

Mainz Biomed to Participate in the 38th Annual GARPS Meeting in Rhineland-Palatinate

Nov 10 2025Newsfilter

Mainz Biomed to Showcase Innovations in Colorectal Cancer Screening at WEO CRC Screening Committee Meeting

Sep 30 2025Newsfilter

Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®

Aug 13 2025Newsfilter

Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants

Aug 04 2025Newsfilter

Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition

Jul 15 2025Newsfilter

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test

Jun 25 2025Newsfilter

Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

Jun 10 2025Newsfilter

Mainz Biomed Initiates Feasibility Study Of PancAlert Blood Test For Pancreatic Cancer Detection

Jun 10 2025NASDAQ.COM